Brittle Diabetes: A Comprehensive Overview

Introduction

Brittle diabetes, also known as labile diabetes, is a rare and severe form of diabetes mellitus characterised by extreme instability of blood glucose levels. Unlike the more common forms of diabetes, brittle diabetes presents with frequent, unpredictable swings between hyperglycaemia (high blood sugar) and hypoglycaemia (low blood sugar), often requiring repeated hospitalisations and intensive medical intervention. Its prevalence is low, affecting less than 1% of individuals with insulin-dependent diabetes, but the impact on patients’ lives is profound, making understanding and management of this condition a clinical priority for medical professionals, students, and patients alike.

Definition and Overview

Brittle diabetes is most commonly seen in individuals with Type 1 diabetes, though rare cases in Type 2 and other forms have been reported. The term “brittle” refers to the condition’s unpredictable nature, where standard diabetes management protocols fail to maintain stable glycaemic control. These patients experience frequent and severe episodes of both hyperglycaemia and hypoglycaemia, often with little warning or apparent cause. The condition can be debilitating, leading to significant psychological distress and a diminished quality of life for affected individuals.

Pathophysiology: Underlying Mechanisms

The pathophysiology of brittle diabetes is complex and multifactorial. While all forms of diabetes are characterised by impaired insulin production or utilisation, brittle diabetes involves additional factors that disrupt glycaemic stability. In most cases, there is an underlying dysfunction in the counter-regulatory mechanisms that normally buffer blood glucose swings. This may include abnormal hormonal responses (such as glucagon, cortisol, and adrenaline), autonomic nervous system dysregulation, and impaired absorption of insulin from subcutaneous tissues.

Brittle diabetes differs from typical Type 1 diabetes in its clinical course. While most patients with Type 1 diabetes can achieve reasonable glycaemic control with structured insulin regimens, those with brittle diabetes experience glycaemic fluctuations despite adherence to treatment. Psychological and psychosocial stressors, gastrointestinal motility disorders (such as gastroparesis), and comorbid endocrine conditions (e.g., thyroid dysfunction) may further contribute to its pathophysiology.

Causes and Risk Factors

The exact causes of brittle diabetes are not fully understood, but several contributing factors have been identified:

• Genetic Predisposition: Some evidence suggests a genetic component, with susceptibility linked to certain human leukocyte antigen (HLA) types and familial clustering of autoimmune conditions.
• Psychosocial Factors: Mental health issues such as depression, anxiety, and eating disorders can significantly affect glycaemic control. Stress hormones influence insulin sensitivity and glucose production, exacerbating instability.
• Gastrointestinal Disorders: Conditions like diabetic gastroparesis, which delay gastric emptying, can make timing of insulin administration challenging and unpredictable.
• Hormonal Imbalances: Coexisting endocrine disorders, including thyroid dysfunction and adrenal insufficiency, may disrupt metabolic balance.
• Insulin Absorption Variability: Scar tissue at injection sites, lipodystrophy, and variations in subcutaneous blood flow can lead to erratic absorption of insulin.
• Environmental Factors: Infections, changes in routine, and dietary inconsistencies can precipitate glycaemic instability.
• Comorbid Medical Conditions: Renal impairment, liver dysfunction, and other chronic illnesses may compound difficulties in glucose regulation.

Symptoms and Diagnosis

The clinical presentation of brittle diabetes is marked by unpredictable and frequent episodes of both hyperglycaemia and hypoglycaemia, often with rapid transitions between the two states. Common symptoms include:

• Frequent dizziness, confusion, or loss of consciousness due to hypoglycaemia
• Polyuria, polydipsia, and blurred vision during hyperglycaemic episodes
• Unexplained fatigue and weakness
• Recurrent hospital admissions for diabetic emergencies
• Weight loss or gain not explained by diet or medication
• Psychological distress, including anxiety and depression

Diagnostic Criteria and Assessment Methods:

Diagnosis is primarily clinical, based on the history of glycaemic instability despite adherence to prescribed management. Key assessment methods include:

1. Detailed patient history, focusing on frequency and severity of glycaemic swings
2. Review of blood glucose logs, continuous glucose monitoring (CGM) data, and HbA1c trends
3. Assessment of insulin regimen and injection technique
4. Screening for comorbid psychological and medical conditions
5. Evaluation of gastrointestinal function (e.g., gastric emptying studies for gastroparesis)
6. Laboratory work-up to rule out endocrine disorders and organ dysfunction

It is essential to differentiate brittle diabetes from poorly controlled diabetes due to non-adherence or inadequate education. Brittle diabetes is characterised by instability despite optimal management and patient engagement.

Management Strategies

Management of brittle diabetes is challenging and typically requires a multidisciplinary approach. The goals are to minimise glycaemic variability, prevent acute complications, and improve quality of life. Strategies include:

Medical Treatments

• Intensive Insulin Therapy: Multiple daily injections or continuous subcutaneous insulin infusion (CSII) via insulin pumps are standard. Insulin analogues with rapid onset and predictable action profiles are preferred.
• Continuous Glucose Monitoring (CGM): CGM devices provide real-time glucose readings, enabling timely intervention for fluctuations and facilitating pattern recognition.
• Adjunctive Medications: In some cases, medications such as pramlintide, which modulate gastric emptying and suppress glucagon, may be used.
• Treatment of Comorbidities: Addressing underlying gastrointestinal, endocrine, or psychiatric conditions is vital for stabilising glycaemic control.

Lifestyle Modifications

• Structured Meal Planning: Consistent carbohydrate intake and meal timing can reduce unpredictability.
• Physical Activity: Regular exercise, tailored to the patient’s capabilities and monitored for glycaemic effects.
• Stress Management: Psychological interventions, such as cognitive behavioural therapy (CBT), can help mitigate stress-induced glycaemic swings.
• Education and Support: Ongoing diabetes education and peer support groups are critical for empowering patients and families.

Monitoring and Technology

• Frequent Blood Glucose Monitoring: Regular self-monitoring and use of CGM systems to detect and respond to trends.
• Insulin Pump Therapy: CSII allows for flexible dosing and basal rate adjustments, reducing the risk of hypoglycaemia.
• Automated Insulin Delivery Systems: Emerging technologies, such as hybrid closed-loop systems (“artificial pancreas”), offer promise for improved stability.

Complications

The unpredictable nature of brittle diabetes increases the risk of both acute and chronic complications.

Acute Complications

• Severe Hypoglycaemia: Loss of consciousness, seizures, and risk of accidents or injury.
• Diabetic Ketoacidosis (DKA): Frequent episodes due to rapid swings into hyperglycaemia.
• Electrolyte Imbalances: Fluctuations in blood glucose can disrupt fluid and electrolyte homeostasis.

Chronic Complications

• Microvascular Damage: Increased risk of retinopathy, nephropathy, and neuropathy due to repeated glycaemic excursions.
• Cardiovascular Disease: Unstable blood glucose places additional strain on the cardiovascular system.
• Impaired Wound Healing: Frequent hyperglycaemia delays tissue repair and increases infection risk.
• Psychological Morbidity: Higher rates of depression, anxiety, and diabetes-related distress.

Psychosocial Impact

Brittle diabetes profoundly affects the quality of life of patients and their families. The unpredictable swings in blood glucose can lead to constant fear of emergencies, social isolation, and disruption of daily activities. Patients may experience:

• Heightened anxiety and depression due to lack of control
• Strained family relationships as loved ones struggle to support and respond to medical crises
• Impaired academic or occupational functioning due to frequent absences
• Stigma and misunderstanding from peers and employers
• Financial burden from repeated hospitalisations and advanced technology use

Empathy and psychological support are essential components of care. Integrating mental health professionals into diabetes care teams can help patients and families cope with the ongoing challenges.

Nursing Care of Patients with Brittle Diabetes

Assessment

Comprehensive Health History:

1. Frequency, duration, and triggers of hypoglycaemic and hyperglycaemic episodes
2. Medication adherence and insulin regimen
3. Dietary habits and lifestyle factors
4. Presence of comorbidities and diabetes-related complications
5. Psychosocial factors such as stress, depression, or anxiety

Physical Assessment:

1. Vital signs monitoring (especially blood pressure and heart rate)
2. Signs of dehydration, infection, or neuropathy
3. Neurological assessment for cognitive changes

Laboratory Investigations:

1. Frequent blood glucose monitoring (including fasting, postprandial, and random)
2. HbA1c to assess long-term control
3. Electrolyte levels, renal function, and ketone testing as indicated

Planning and Implementation

Blood Glucose Monitoring:

1. Encourage frequent self-monitoring and use of continuous glucose monitoring (CGM) if available
2. Document and analyse trends to identify patterns and triggers
3. Promptly address hypo- and hyperglycaemic episodes

Medication Management:

1. Ensure accurate insulin administration and correct dosing
2. Monitor for insulin errors or missed doses
3. Assess for the need of insulin pump therapy in consultation with the healthcare team

Dietary Management:

1. Collaborate with dietitians to develop an individualised meal plan
2. Educate patients on carbohydrate counting, meal timing, and the importance of consistency
3. Advise on the management of sick days and unplanned physical activity

Management of Acute Episodes:

1. Recognise and treat hypoglycaemia immediately (oral glucose, intravenous dextrose if unconscious)
2. Manage hyperglycaemia with appropriate insulin adjustments and hydration
3. Monitor for signs of diabetic ketoacidosis (DKA) and hyperosmolar hyperglycaemic state (HHS)

Patient Education:

1. Teach signs and symptoms of hypo- and hyperglycaemia
2. Train in the use of glucometers, insulin pens, and CGM devices
3. Provide guidance on the management of emergencies
4. Encourage wearing medical alert identification

Psychosocial Support:

1. Address emotional distress, anxiety, or depression related to unstable diabetes
2. Facilitate access to counselling or support groups
3. Encourage family involvement in care and education

Coordination of Care:

1. Collaborate with endocrinologists, dietitians, diabetes educators, and mental health professionals
2. Ensure regular follow-up and effective communication among the healthcare team

Evaluation

• Assess for reduction in frequency and severity of glucose fluctuations
• Monitor for absence of acute complications (DKA, severe hypoglycaemia)
• Evaluate patient’s knowledge and adherence to self-management strategies
• Assess improvement in psychological wellbeing and quality of life

Special Considerations

• Children, adolescents, and elderly patients may require tailored approaches
• Consider cultural beliefs, literacy levels, and socioeconomic factors affecting diabetes management
• Be vigilant for signs of diabetes burnout and provide appropriate interventions

REFERENCES

1. National Organization for Rare Disorders (U.S.). Brittle Diabetes. https://rarediseases.org/gard-rare-disease/brittle-diabetes/.
2. Singh Kochar I, Jain R. Pancreas transplant in type 1 diabetes mellitus: the emerging role of islet cell transplant. Ann Pediatr Endocrinol Metab. 2021;26(2):86-91.
3. Hirsch IB, Gaudiani LM. A new look at brittle diabetes. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7266594/. J Diabetes Complications. 2021 Jan;35(1):107646.
4. Newman C, Dinneen SF. Brittle diabetes revisited: a description of erratic and difficult-to-control diabetes in an elderly woman with Type 1 diabetes. Diabet Med. 2020;37(10):1777-1780.
5. Thewjitcharoen Y, Viriyautsahakul V, Sasijaroenrat N, et al. Celiac disease as a cause of anemia and brittle diabetes in type 1 diabetes mellitus. J ASEAN Fed Endocr Soc. 2021;36(2):227-230.
6. Beyond Type 1. What is Brittle Diabetes?. https://beyondtype1.org/what-is-brittle-diabetes/ Last updated 12/26/2022.
7. Liu J, Zhou L, Sun L, et al. Association between intestinal Prevotella copri abundance and glycemic fluctuation in patients with brittle diabetes. Diabetes Metabol Syndr Obes. 2023;2023(16):1613-1621.

Stories are the threads that bind us; through them, we understand each other, grow, and heal.

JOHN NOORD

Connect with “Nurses Lab Editorial Team”

I hope you found this information helpful. Do you have any questions or comments? Kindly write in comments section. Subscribe the Blog with your email so you can stay updated on upcoming events and the latest articles.